Hepatitis C virus (HCV) has the lymphotropic feature that is supposed to be the reason of related extrahepatic manifestation. HCV viral oncoproteins may participate in the regulation of some gene expression that has been implicated in tumorigenesis. Our aim is to evaluate the HCV-NS4 circulating levels in breast cancer (BC) and to investigate its relation with BC tumor aggressiveness.
This study was performed among 158 Egyptian women (120 with BC and 38 with benign breast diseases). ELISA was used for detection of anti-HCV antibodies, HCV-NS4, fibronectin, and CA 15-3.
No association between HCV detection in this group of BC patients (27.5% in BC vs. 23.7% in breast benign diseases, P = 0.687). Among HCV-infected patients, the mean HCV-NS4 serum level in BC was significantly higher than benign group (61.7 μg/mL vs. 33.9 μg/mL, P = 0.0005). Fibronectin levels were higher (P = 0.014) in patients infected with HCV than noninfected BC patients. Elevated HCV-NS4 levels were associated with tumor severity features like large size, late stages, high grades, and infiltrated lymph nodes. The elevated levels of HCV-NS4 (> 40 μg/mL) yielded an estimated odds ratio (95% confidence intervals) of 2.5 (0.98–6.36), 1.2 (0.44–3.33), 1.9 (0.53–7.00), and 2.5 (0.87–7.33) for developing large size, late stages, high grades, and infiltrated lymph nodes, respectively. Interestingly, HCV-NS4 levels significantly correlated with other BC tumor marker like CA15-3 (r = 0.535; P = 0.0009) and fibronectin (r = 0.432; P < 0.0001).
HCV-NS4 appears to be associated with BC progression features. Oncologists treating such BC patients should consider HCV screening to enable the early identification and to prevent progression of the disease.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. Cancer J Clin. 2015;65:87–108.
Hamilton R, Williams JK, Bowers BJ, Calzone K. Life trajectories, genetic testing, and risk reduction decisions in 18–39 year old women at risk for hereditary breast and ovarian cancer. J Genet Couns. 2009;18:147–59.
Richardson A. Is breast cancer caused by late exposure to a common virus? Med Hypotheses. 1997;48:491–7.
Fiorino S, Bacchi-Reggiani L, De Biase D, et al. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: a systematic review. World J Gastroenterol. 2015;21:12896–953.
Carrozzo M, Quadri R, Latorre P, et al. Molecular evidence that the hepatitis C virus replicates in the oral mucosa. J Hepatol. 2002;37:364–9.
Crovatto M, Pozzato G, Zorat F, et al. Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virus. Haematologica. 2000;85:356–61.
Sansonno D, Lauletta G, Montrone M, Grandaliano G, Schena FP, Dammacco F. Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection. Clin Exp Immunol. 2005;140:498–506.
Toussirot E, Le Huede G, Mougin C, Balblanc JC, Bettinger D, Wendling D. Presence of hepatitis C virus RNA in the salivary glands of patients with Sjogren’s syndrome and hepatitis C virus infection. J Rheumatol. 2002;29:2382–5.
Kurokawa M, Hidaka T, Sasaki H, Nishikata I, Morishita K, Setoyama M. Analysis of hepatitis C virus (HCV) RNA in the lesions of lichen planus in patients with chronic hepatitis C: detection of anti-genomic- as well as genomic-strand HCV RNAs in lichen planus lesions. J Dermatol Sci. 2003;32:65–70.
Fm Yan, As Chen, Hao F, et al. Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World J Gastroenterol. 2000;6:805–11.
Su Fh, Sn Chang, Pc Chen, Sung Fc Su, Ct Yeh Cc. Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control study. Bmc Cancer. 2011;11:495.
Larrey D, Bozonnat MC, Kain I, Pageaux GP, Assenat E. Is chronic hepatitis C virus infection a risk factor for breast cancer? World J Gastroenterol. 2010;16:3687–91.
Mclaughlin-Drubin ME, Munger K. Viruses associated with human cancer. Biochim Biophys Acta. 2008;1782:127–50.
Jj Zhou, Rf Chen, Xg Deng, et al. Hepatitis C virus core protein regulates nanog expression via the stat3 pathway. FEBS Lett. 2014;588:566–73.
My Chen, Zq Huang, Lz Chen, Yb Gao, Ry Peng, Dw Wang. Detection of hepatitis C virus Ns5 protein and genome in chinese carcinoma of the extrahepatic bile duct and its significance. World J Gastroenterol. 2000;6:800–4.
Takaki A, Tatsukawa M, Iwasaki Y, et al. Hepatitis C virus Ns4 protein impairs the Th1 polarization of immature dendritic cells. J Viral Hepat. 2010;17:555–62.
Attallah AM, Ismail H, Shiha GE, Abou-Dobara MI, El-Sherbiny RE, El-Dosoky I. Immunochemical identification and partial characterization of a native hepatitis C viral non-structural 4 antigen in sera of HCV infected patients. Clin Chim Acta. 2008;388:115–22.
Attallah AM, Zahran F, Ismail H, Omran MM, El-Dosoky I, Shiha GE. Immunochemical identification and detection of serum fibronectin in liver fibrosis patients with chronic hepatitis C. J Immunoassay Immunochem. 2007;28:331–42.
Jm Pawlotsky, Ben Yahia M, Andre C, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology. 1994;19:841–8.
Chen Y, Williams V, Filippova M, Filippov V, Duerksen-Hughes P. Viral carcinogenesis: factors inducing DNA damage and virus integration. Cancers (Basel). 2014;6:2155–86.
Ak Witkiewicz, Es Knudsen. Retinoblastoma tumor suppressor pathway in breast cancer: prognosis, precision medicine, and therapeutic interventions. Breast Cancer Res. 2014;16:207.
Munakata T, Nakamura M, Liang Y, Li K, Lemon SM. Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus Ns5b RNA-dependent rna polymerase. Proc Natl Acad Sci USA. 2005;102:18159–64.
Qadri I, Iwahashi M, Simon F. Hepatitis C virus Ns5a protein binds Tbp and P53, inhibiting their DNA binding and p53 interactions with Tbp and Ercc3. Biochim Biophys Acta. 2002;1592:193–204.
Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus nonstructural protein Ns3 transforms Nih 3t3 cells. J Virol. 1995;69:3893–6.
Song LL, Miele L. Cancer stem cells–an old idea that’s new again: implications for the diagnosis and treatment of breast cancer. Expert Opin Biol Ther. 2007;7:431–8.
Ali N, Allam H, May R, et al. Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts. J Virol. 2011;85:12292–303.
Fernandez-Garcia B, Eiro N, Marin L, et al. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis. Histopathology. 2014;64:512–22.
Conflict of interest
The authors declare that they have no conflict of interest.
About this article
Cite this article
Attallah, A.M., El-Far, M., Abdelrazek, M.A. et al. HCV nonstructural protein 4 is associated with aggressiveness features of breast cancer. Breast Cancer 25, 297–302 (2018). https://doi.org/10.1007/s12282-017-0829-1
- Breast cancer
- Hepatitis C virus
- Viral proteins
- Extrahepatic malignancies